Tiny Health, established in 2020, is revolutionizing the Biotechnology and Health Care sectors with its comprehensive, at-home microbiome health platform aimed at individuals throughout various life stages, from pregnancy to healthy aging. Known for its slogan, "There are 38 trillion reasons to care about your microbiome," Tiny Health specializes in advanced gut and vaginal microbiome testing, leveraging shotgun metagenomic sequencing and AI-driven analysis. Noteworthy collaborations include the prestigious Mayo Clinic and leading figures like Dr. Emeran Mayer and Dr. Elisa Song.
Recently, Tiny Health raised $8.50M in a Series A funding round on 01 March 2024, with investments from reputable firms like Conscience, Next Coast Ventures, Peterson Ventures, and others. With endorsements from over 80,000 families and a milestone clinical study reducing atopic condition risks by 83%, the company is poised for substantial growth thanks to its expert team from elite institutions like Mayo Clinic, Johns Hopkins, and Harvard Medical School.
